Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Mon, 07/24/23 - 09:35 pm
Teva Pharmaceutical
Alvotech
biosimilars
Humira
AbbVie
drug manufacturing
Four Crucial Questions about the Humira Biosimilar Price War
Drug Channels
Tue, 07/18/23 - 11:38 am
AbbVie
Humira
biosimilars
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
Fri, 07/7/23 - 06:53 am
biosimilars
Mark Cuban
Mark Cuban Cost Plus Drugs
AbbVie
Humira
Coherus Biosciences
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
BioSpace
Wed, 07/5/23 - 11:44 am
Pfizer
Samsung BioLogics
drug manufacturing
biosimilars
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Alvotech
Teva Pharmaceutical
AbbVie
Humira
biosimilars
FDA
Sandoz targets barriers to biosimilar accessibility with latest initiative
Pharmaceutical Technology
Thu, 06/15/23 - 07:00 pm
Sandoz
Novartis
patient access
biosimilars
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
Thu, 06/15/23 - 06:55 pm
AbbVie
Humira
biosimilars
Mark Cuban Cost Plus Drugs
Coherus Biosciences
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Herceptin shows biosimilar markets can work. To what extent is the question.
Medical Marketing and Media
Sun, 06/11/23 - 11:12 pm
Herceptin
biosimilars
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Novartis
Sandoz
generics
biosimilars
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Pharmaceutical Business Review
Thu, 06/8/23 - 09:45 am
Samsung BioLogics
Pfizer
biosimilars
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
Fierce Pharma
Thu, 06/1/23 - 06:35 pm
Novartis
biosimilars
spinoffs
headquarters
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Novartis
Sandoz
biosimilars
generics
women executives
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Wed, 05/10/23 - 10:00 am
Novartis
Sandoz
Evotec
biosimilars
As Humira biosims take hold, longtime AbbVie CEO Richard Gonzalez talks succession plans
Fierce Pharma
Thu, 04/27/23 - 11:02 pm
AbbVie
Pharma CEOs
Richard Gonzalez
Humira
biosimilars
Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA
Business Insider
Mon, 04/17/23 - 11:06 pm
Teva Pharmaceutical
Alvotech
AVT02
FDA
Humira
biosimilars
FDA rejects Teva’s high-potency biosimilar of Humira again
Pharmaphorum
Fri, 04/14/23 - 10:37 am
Teva Pharmaceutical
Alvotech
biosimilars
FDA
Humira
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »